Beta-sitosterol’s prostate-relieving power was confirmed in a double-blind, placebo-controlled clinical study published in the prestigious British medical journal The Lancet. 200 patients took either 20 mg. of beta-sitosterol or a placebo three times per day.
The men who took the beta-sitosterol saw their symptoms decrease by nearly 50%! Their urine flow increased 35%! Voiding time plummeted 32%. These are major improvements in urine flow!5
These are real results published in one of the world’s most renowned medical journals!
Bioperine® BioPerine® is an extract obtained from the black pepper fruit. The extract of piperine, called BioPerine® in the patented form, significantly enhances the bioavailability of various supplement nutrients through increased absorption.
Beta-sitosterol. Numerous plants contain cholesterol-like compounds called sitosterols and their close relatives sitosterolins. A special mixture of these, called beta-sitosterol, is used for the treatment of BPH. A review of the literature, published in 1999, found a total of four randomized double-blind, placebo-controlled studies on beta-sitosterol for BPH, enrolling a total of 519 men. All but one of these studies found significant benefits in both perceived symptoms and objective measurements, such as urine flow rate. The largest trial followed 200 men with BPH for a period of 6 months. After the study was completed, many of the participants were followed for an additional year, during which the benefits continued. Similar results were seen in a 6-month, double-blind trial of 177 individuals with BPH.
Selenium With age, selenium is poorly absorbed into the body and rapidly depleted. Therefore, older adults usually have selenium deficiency, and this deficiency is associated with failing prostate health in men. Selenium benefits the prostate with its antioxidant protection. Because it is used by the body to make selenoproteins which are essential for neutralizing free radicals in the body, selenium can help prevent the oxidative destruction of prostate epithelial cells. This antioxidant protection has also been shown to reduce the risk of prostate cancer and also fight the growth of cancerous cells. Selenium reduces the activities and production of prostate-specific antigens. These antigens are also known as gamma-seminoproteins. They are produced by cells of the prostate gland and rarely found in the serum.By inhibiting PSA in men, selenium may help reduce the risk of prostate cancer and the progression of benign prostate hyperplasia.
Pomegranate Pomegranate compounds suppress enzymes in the intestine and liver that convert certain molecules (procarcinogens) into cancer-causing agents. In men with prostate cancer, the active constituents in pomegranate are potent inducers of malignant cell death through apoptosis. During the development of androgen independence, prostate cancer cells are known to increase testosterone synthesis inside their own cells, which maintains cancer cell growth in the absence of significant amounts of circulating testosterone. Overexpression of the androgen receptor occurs in androgen-independent prostate cancer and has been proposed as another mechanism promoting the development of androgen independence. Pomegranate has been shown to inhibit expression of the androgen receptor and androgen synthesizing genes in prostate cells, which helps block an important survival mechanism utilized by prostate cancer cells to escape eradication. Multiple studies have demonstrated that pomegranate treatment slows PSA doubling time and reduces production of PSA in malignant prostate cells.
Added prostate cancer-fighting benefits of pomegranate include reduction of the inflammation that drives cancer progression, suppression of new blood vessel growth within a forming prostate tumor, and increased expression of genes that keep cells clumped together normally, thereby inhibiting the invasive potential of prostate cancer.
Green Tea Green tea contains a special combination of naturally occurring polyphenols called catechins. Studies show that one of green tea’s catechins, EGCG, accumulates specifically in prostate tissue, where it selectively kills cancer cells (leaving healthy cells unaffected) and reduces serum PSA levels. Researchers studied men with a pre-cancerous condition called prostate intraepithelial neoplasia and found only one tumor after one year in the 30 men given green tea polyphenols, while the 30 placebo recipients developed nine cancers. The compnents in Green Tea reduce genetic expression and activity of androgen receptors that most prostate cancers need to survive.
Turmeric A study was designed to determine the efficacy of curcumin in the prevention of prostate cancer metastases, and to determine exactly how the compound worked at the cellular level. Both prostate and breast cancer lines are associated with an increase in the pro-inflammatory cytokines, CXCL 1 and CXCL 2, and are believed to spread throughout the body to other organs and tissues through the release of these chemical messengers.
The study team found that curcumin alters the expression of these two destructive proteins and directly inhibits the metastatic spread of prostate cancer cells. They concluded that “due to the action of curcumin, the tumor cells synthesize smaller amounts of cytokines that promote metastasis… as a consequence, the frequency of metastasis formation in the lungs is significantly reduced, in animals with breast cancer, or carcinoma of the prostate, as demonstrated in the new study.”
Broccoli Broccoli’s unique contribution to prostate-cancer-fighting is its ability to up-regulate phase II detoxifying enzymes in gut and liver tissue, enabling the body to render harmless thousands of potentially carcinogenic molecules in our diet. In addition, the naturally occurring sulphur-rich broccoli constituents sulforaphane, indole-3-carbinol (I3C), and others have now been identified as potent epigenetic regulators. These broccoli compounds control enzymes called histone deacetylases (HDAC) that regulate the genes encoded in DNA—including those responsible for promoting or suppressing cancer formation. Broccoli compounds reduce PSA production as a result of slowing prostate cancer cell replication in laboratory cell culture models. They appear to inhibit expression of the androgen receptors that prostate cancer needs to survive. Broccoli’s other prostate cancer-fighting properties include inhibition of growth and transcription factors that are activated in malignancies, restoration of normal tumor suppressor genes, and increased production of apoptosis-inducing proteins
For the first time pomegranate, green tea, turmeric and broccoli have been scientifically proven to fight prostate cancer, the most common cancer in men in the UK.
A six-month trial at Bedford involving 203 men with prostate cancer showed that PSA levels of those who took a capsule containing essence of pomegranate, green tea, turmeric and broccoli were 63% less than those who took the placebo. The PSA is a level of the protein produced by the prostate gland which is an indicator of prostate cancer.
Researchers have previously concentrated on extracting chemicals such as minerals, lycopene and vitamins from foods and putting these into supplements - most studies, however, showed they did more harm than good in terms of cancer risk.
Although polyphenol-rich foods such as pomegranate, green tea, turmeric and broccoli have demonstrated multiple anti-cancer effects in laboratory tests, and small non-randomised studies, this is the first time they have firmly established an influence on markers of cancer progression within a scientifically robust evaluation.
Prostate enlargement is becoming increasingly common as men are living longer lives. About 30 million men suffer from benign prostatic hypertrophy (BPH). BPH is the most common disorder of the prostate and it is the most common diagnosis by urologists for male patients age 45-74. There is a 50 percent chance that you will have prostate problems or symptoms by the time you are 60. Each year more than 500,000 men in North America have prostate surgery. Prostate surgery often results in both incontinence and impotence and can result in men living a life without sexual intercourse.
PSA-Fast contains potent levels of synergistic herbs, nutrients and phytochemicals that have been scientifically researched to support the health and wellness of the prostate gland.
You should take PSA-Fast if you.....
- want to keep your prostate gland healthy.
- want to PREVENT PROSTATE PROBLEMS
- have pain or a burning sensation while urination
- urinate frequently
- have a reduction or difficulty in the flow of urine
- have a prostate problem.
Statistics on Prostate Cancer from around the world.
Other than skin cancer, prostate cancer is the most common cancer in men. Worldwide, more than 1.11 million men were estimated to have been diagnosed with prostate cancer in 2012, with incidence rates varying across the world. Prostate cancer occurs mainly in older men. About 6 cases in 10 are diagnosed in men aged 65 or older, and it is rare before age 40. The average age at the time of diagnosis is about 66. The level of awareness, understanding and support for prostate cancer lags significantly behind that of women’s health causes.
United States of America. The American Cancer Society’s estimates for prostate cancer in the United States for 2016/7 are:
About 233,000 new cases of prostate cancer will be diagnosed
About 29,480 men will die of prostate cancer
What Is Benign Prostatic Hyperplasia?
Benign prostatic hyperplasia (BPH) is a noncancerous (benign) enlargement of the prostate gland. The word “hyperplasia” refers to the growth of tissue that occurs because of an increase in the number of cells in the prostate. In men who have BPH, the prostate gland, which is normally about 20 to 30 grams and the size of a walnut, can grow to as much as 50 to 100 grams.
BPH affects more than 50% of men older than 50, and by age 80, nearly all men (90%) have an enlarged prostate. However, not all men experience symptoms of BPH, and when symptoms are present, they may be mild and not require treatment.
About 1 man in 7 will be diagnosed with prostate cancer during his lifetime.
Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. About 1 man in 36 will die of prostate cancer.
Europe and the UK. Prostate cancer is the most common cancer in men in the UK.
In 2015 in the UK around 41,700 men were diagnosed with prostate cancer, that's more than 110 every day. Over the last 35 years prostate cancer rates in Great Britain have more than tripled, although much of the increase is due to increased detection through widespread use of the PSA test.
In Europe, around 417,000 new cases of prostate cancer were estimated to have been diagnosed in 2016.
South Africa. Prostate cancer is the most prevalent cancer among males. More than 4300 men are newly diagnosed each year with 2000 men dying from this disease each year.
South African men have a 1 in 23 lifetime risk for prostate cancer
One in seven men will be diagnosed by age 75
One in four will be diagnosed by age 85
Around 5 men die from prostate cancer each day in South Africa – calculation based on 2000 men dying yearly. It is estimated that 238,590 men will be diagnosed with and 29,720 men will die of cancer of the prostate in 2016.